BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 27321957)

  • 21. Clinical Significance of EphB4 and EphB6 Expression in Human Malignant and Benign Thyroid Lesions.
    Giaginis C; Alexandrou P; Poulaki E; Delladetsima I; Troungos C; Patsouris E; Theocharis S
    Pathol Oncol Res; 2016 Apr; 22(2):269-75. PubMed ID: 26220827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity.
    Bertherat J; Groussin L; Sandrini F; Matyakhina L; Bei T; Stergiopoulos S; Papageorgiou T; Bourdeau I; Kirschner LS; Vincent-Dejean C; Perlemoine K; Gicquel C; Bertagna X; Stratakis CA
    Cancer Res; 2003 Sep; 63(17):5308-19. PubMed ID: 14500362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Similar and divergent patterns in the regulation of matrix metalloproteinase-1 (MMP-1) and tissue inhibitor of MMP-1 gene expression in benign and malignant human thyroid cells.
    Korem S; Resnick MB; Kraiem Z
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3322-7. PubMed ID: 10487706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of cd56 and e-cadherin expression in the differential diagnosis of papillary thyroid carcinoma and suspected follicular-patterned lesions of the thyroid: the prognostic importance of e-cadherin.
    Ceyran AB; Şenol S; Şimşek BÇ; Sağıroğlu J; Aydın A
    Int J Clin Exp Pathol; 2015; 8(4):3670-80. PubMed ID: 26097548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of the ring ligase PRAJA2 in thyroid cancer.
    Cantara S; D'Angeli F; Toti P; Lignitto L; Castagna MG; Capuano S; Prabhakar BS; Feliciello A; Pacini F
    J Clin Endocrinol Metab; 2012 Nov; 97(11):4253-9. PubMed ID: 22948757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utility of contrast-enhanced ultrasound for evaluation of thyroid nodules.
    Zhang B; Jiang YX; Liu JB; Yang M; Dai Q; Zhu QL; Gao P
    Thyroid; 2010 Jan; 20(1):51-7. PubMed ID: 20067379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thyroid-specific ablation of the Carney complex gene, PRKAR1A, results in hyperthyroidism and follicular thyroid cancer.
    Pringle DR; Yin Z; Lee AA; Manchanda PK; Yu L; Parlow AF; Jarjoura D; La Perle KM; Kirschner LS
    Endocr Relat Cancer; 2012 Jun; 19(3):435-46. PubMed ID: 22514108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Significance of Hu-Antigen Receptor (HuR) and Cyclooxygenase-2 (COX-2) Expression in Human Malignant and Benign Thyroid Lesions.
    Giaginis C; Alexandrou P; Delladetsima I; Karavokyros I; Danas E; Giagini A; Patsouris E; Theocharis S
    Pathol Oncol Res; 2016 Jan; 22(1):189-96. PubMed ID: 26498465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein kinase A effects of an expressed PRKAR1A mutation associated with aggressive tumors.
    Meoli E; Bossis I; Cazabat L; Mavrakis M; Horvath A; Stergiopoulos S; Shiferaw ML; Fumey G; Perlemoine K; Muchow M; Robinson-White A; Weinberg F; Nesterova M; Patronas Y; Groussin L; Bertherat J; Stratakis CA
    Cancer Res; 2008 May; 68(9):3133-41. PubMed ID: 18451138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C Cell and Follicular Epithelial Cell Precursor Lesions of the Thyroid.
    Scognamiglio T
    Arch Pathol Lab Med; 2017 Dec; 141(12):1646-1652. PubMed ID: 28644684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of cyclic adenosine 3',5'-monophosphate/protein kinase a pathway on markers of cell proliferation in nonfunctioning pituitary adenomas.
    Mantovani G; Bondioni S; Ferrero S; Gamba B; Ferrante E; Peverelli E; Corbetta S; Locatelli M; Rampini P; Beck-Peccoz P; Spada A; Lania AG
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6721-4. PubMed ID: 16204369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of Pax-8, p53 and bcl-2 in human benign and malignant thyroid diseases.
    Puglisi F; Cesselli D; Damante G; Pellizzari L; Beltrami CA; Di Loreto C
    Anticancer Res; 2000; 20(1A):311-6. PubMed ID: 10769673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutational analysis of PRKAR1A and Gs(alpha) in sporadic adrenocortical tumors.
    Libé R; Mantovani G; Bondioni S; Lania AG; Pedroni C; Beck-Peccoz P; Spada A
    Exp Clin Endocrinol Diabetes; 2005 May; 113(5):248-51. PubMed ID: 15926108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of nonneoplastic endocrine hyperplasia--a changing concept: a review focused on the thyroid gland.
    Studer H; Derwahl M
    Endocr Rev; 1995 Aug; 16(4):411-26. PubMed ID: 8521787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequent silencing of RASSF1A via promoter methylation in follicular thyroid hyperplasia: a potential early epigenetic susceptibility event in thyroid carcinogenesis.
    Brown TC; Juhlin CC; Healy JM; Prasad ML; Korah R; Carling T
    JAMA Surg; 2014 Nov; 149(11):1146-52. PubMed ID: 25229773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential expression of S100C in thyroid lesions.
    Torres-Cabala C; Panizo-Santos A; Krutzsch HC; Barazi H; Namba M; Sakaguchi M; Roberts DD; Merino MJ
    Int J Surg Pathol; 2004 Apr; 12(2):107-15. PubMed ID: 15173915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of telomerase genes in thyroid carcinoma.
    Hoang-Vu C; Boltze C; Gimm O; Poremba C; Dockhorn-Dworniczak B; Köhrle J; Rath FW; Dralle H
    Int J Oncol; 2002 Aug; 21(2):265-72. PubMed ID: 12118320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential role of PKA catalytic subunits in mediating phenotypes caused by knockout of the Carney complex gene Prkar1a.
    Yin Z; Pringle DR; Jones GN; Kelly KM; Kirschner LS
    Mol Endocrinol; 2011 Oct; 25(10):1786-93. PubMed ID: 21852354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclooxygenase-2 in normal, hyperplastic and neoplastic follicular cells of the human thyroid gland.
    García-González M; Abdulkader I; Boquete AV; Neo XM; Forteza J; Cameselle-Teijeiro J
    Virchows Arch; 2005 Jul; 447(1):12-7. PubMed ID: 15947945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upregulation of HMGA2 in thyroid carcinomas: a novel molecular marker to distinguish between benign and malignant follicular neoplasias.
    Belge G; Meyer A; Klemke M; Burchardt K; Stern C; Wosniok W; Loeschke S; Bullerdiek J
    Genes Chromosomes Cancer; 2008 Jan; 47(1):56-63. PubMed ID: 17943974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.